Research Topics
| Mark ParascandolaSummaryAffiliation: National Institutes of Health Country: USA Publications
|
Detail Information
Publications
A turning point for conflicts of interest: the controversy over the National Academy of Sciences' first conflicts of interest disclosure policyMark Parascandola
Tobacco Control Research Branch, National Cancer Institute, Bethesda, MD 20892, USA
J Clin Oncol 25:3774-9. 2007..In the absence of a definitive standard, this historical case study can substantially inform ongoing discussion on conflicts of interest in clinical research...- Causation in epidemiologyM Parascandola
Cancer Prevention Fellowship Program, Office of Preventive Oncology, National Cancer Institute, Bethesda, MD 20892 7105, USA
J Epidemiol Community Health 55:905-12. 2001.... - Tobacco harm reduction and the evolution of nicotine dependenceMark Parascandola
Tobacco Control Research Branch, Behavioral Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD 20892 7337, USA
Am J Public Health 101:632-41. 2011..This history has important lessons for current discussions about tobacco harm reduction and regulation of nicotine delivery... - Characteristics of current and recent former smokers associated with the use of new potential reduced-exposure tobacco productsMark Parascandola
Tobacco Control Research Branch, National Cancer Institute, Bethesda, MD 20892, USA
Nicotine Tob Res 11:1431-8. 2009.... - Consumer awareness and attitudes related to new potential reduced-exposure tobacco product brandsMark Parascandola
Division of Cancer Control and Population Sciences, Tobacco Control Research Branch, National Cancer Institute, 6130 Executive Boulevard, Room 4039, Bethesda, MD 20892 7337, USA
Nicotine Tob Res 11:886-95. 2009..Although these products have not been widely used among smokers, there are few data available on consumers' awareness and attitudes toward these products... - Consumer awareness and attitudes related to new potential reduced-exposure tobacco productsMark Parascandola
Tobacco Control Research Branch, National Cancer Institute, 6130 Executive Blvd, Room 4039, Bethesda, MD 20892 7337, USA
Am J Health Behav 32:431-7. 2008..To assess US consumers' awareness of potential reduced-exposure tobacco products (PREPs) and correlates of interest in these products... - Lessons from the history of tobacco harm reduction: The National Cancer Institute's Smoking and Health Program and the "less hazardous cigarette"Mark Parascandola
National Cancer Institute, Bethesda, MD 20892, USA
Nicotine Tob Res 7:779-89. 2005.... - Science, industry, and tobacco harm reduction: a case study of tobacco industry scientists' involvement in the National Cancer Institute's Smoking and Health Program, 1964-1980Mark Parascandola
Tobacco Control Research Branch, National Cancer Institute, Bethesda, MD 20892, USA
Public Health Rep 120:338-49. 2005 - Skepticism, statistical methods, and the cigarette: a historical analysis of a methodological debateMark Parascandola
National Cancer Institute, 6130 Executive Boulevard, Suite 3109, Bethesda, MD 20892, USA
Perspect Biol Med 47:244-61. 2004..These diverging views reflect an underlying tension within the discipline of epidemiology between the search for "objective" methods of scientific inference and the practical needs of public health research that persists today... - Causes, risks, and probabilities: probabilistic concepts of causation in chronic disease epidemiologyMark Parascandola
Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD, USA
Prev Med 53:232-4. 2011..The tension between probabilistic risk factors and deterministic causal mechanisms continues to haunt epidemiology today... - The Strategic Dialogue on Tobacco Harm Reduction: a vision and blueprint for action in the USMitchell Zeller
Pinney Associates, 3 Bethesda Metro Center, Suite 1400, Bethesda, MD 20814, USA
Tob Control 18:324-32. 2009..Short-term and long-term objectives are described... - Uncertain science and a failure of trust. The NIH radioepidemiologic tables and compensation for radiation-induced cancerMark Parascandola
National Cancer Institute, Cancer Prevention Fellowship Program, 6130 Executive Boulevard, Suite 3109, Bethesda, Maryland 20892, USA
Isis 93:559-84. 2002..Additionally, the goal of fairness and objectivity could not be convincingly met because of persistent controversy and mistrust surrounding the government's role in the study of health effects of low-level radiation... - Patient autonomy and the challenge of clinical uncertaintyMark Parascandola
National Cancer Institute, Bethesda, MD, USA
Kennedy Inst Ethics J 12:245-64. 2002..In situations where there is substantial uncertainty, extra vigilance is required to ensure that patients are given the tools and information they need to participate in cooperative decision making about their care... - Two approaches to etiology: the debate over smoking and lung cancer in the 1950sMark Parascandola
Endeavour 28:81-6. 2004..This debate has relevance for current epidemiological practice, as tension between these two views still remains... - Tobacco industry research and protection of human subjects: a case study of R. J. ReynoldsJenny White
Department of Clinical Pharmacy, University of California, San Francisco, CA, USA
Nicotine Tob Res 9:1213-25. 2007..Policymakers should consider expanding the scope of federal human subjects research regulations to cover research undertaken by private firms such as tobacco companies...